
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260 [J. M. M., D. P. C., B. W. D.] Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 [R. B., C. M., B. W. D.] and Cellomics, Inc., Pittsburgh, Pennsylvania 15219 [K. A. G.]
(+)-Discodermolide, a C24:4, trihydroxylated, octamethyl, carbamate-bearing fatty acid lactone originally isolated from a Caribbean sponge, has proven to be the most potent of the microtubule-stabilizing agents. Recent studies suggest that it or its analogues may have advantages over other classes of microtubule-stabilizing agents. (+)-Discodermolides complex molecular architecture has made structure-activity relationship analysis in this class of compounds a formidable task. The goal of this study was to prepare simplified analogues of (+)-discodermolide and to analyze their biological activities to expand structure-activity relationships. A small library of analogues was prepared wherein the (+)-discodermolide methyl groups at C-14 and C-16 and the C-7 hydroxyl were removed, and the lactone was replaced by simple esters. The library components were analyzed for microtubule-stabilizing actions in vitro, antiproliferative activity against a small panel of human carcinoma cells, and cell signaling, microtubule architecture and mitotic spindle alterations by a multiparameter fluorescence cell-based screening technique. The results show that even drastic structural simplification can lead to analogues with actions related to microtubule targeting and signal transduction, but that these subtle effects were illuminated only through the high information content cell-based screen.
This article has been cited by other articles:
![]() |
F. Gasparri, P. Cappella, and A. Galvani Multiparametric Cell Cycle Analysis by Automated Microscopy J Biomol Screen, September 1, 2006; 11(6): 586 - 598. [Abstract] [PDF] |
||||
![]() |
C. J. Wilson, Y. Si, C. M. Thompsons, A. Smellie, M. A. Ashwell, J.-F. Liu, P. Ye, D. Yohannes, and S.-C. Ng Identification of a Small Molecule That Induces Mitotic Arrest Using a Simplified High-Content Screening Assay and Data Analysis Method J Biomol Screen, February 1, 2006; 11(1): 21 - 28. [Abstract] [PDF] |
||||
![]() |
R. N. Ghosh, R. DeBiasio, C. C. Hudson, E. R. Ramer, C. L. Cowan, and R. H. Oakley Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor(R)Technology J Biomol Screen, August 1, 2005; 10(5): 476 - 484. [Abstract] [PDF] |
||||
![]() |
K. A. Giuliano, Y.-T. Chen, and D. L. Taylor High-Content Screening with siRNA Optimizes a Cell Biological Approach to Drug Discovery: Defining the Role of P53 Activation in the Cellular Response to Anticancer Drugs J Biomol Screen, October 1, 2004; 9(7): 557 - 568. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |